Ameriprise’s Rosetta Genomics Ltd. ROSG Stock Holding History

Ameriprise’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-17	Closed	-$1K	–	5753
2014 Q1	$1K	Buy	+17	New	+$878	﹤0.01%	5232

Other funds holding ROSG

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's ROSG Position: Q2 2014 in Review

Ameriprise sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2014, closing a stake of 17 shares — an estimated $1K sold.

Ameriprise first reported a position in ROSG in Q1 2014 and held it in 1 quarter. The position peaked at $1K in Q1 2014. 16 funds tracked by Wall St. Rank hold ROSG as of Q2 2014.

Ameriprise reported no remaining Rosetta Genomics Ltd. position as of Q2 2014 after selling out during the quarter.
Ameriprise sold 17 Rosetta Genomics Ltd. shares in Q2 2014, an estimated $1K.
Ameriprise first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 1 quarter.
Ameriprise's Rosetta Genomics Ltd. position peaked at $1K in Q1 2014.
16 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2014.

Based on Ameriprise's 13F filing for Q2 2014, filed 13 Aug 2014.